Why is sertraline under investigation?: An analysis of safety and efficacy concerns
•
4 min read
According to the FDA, sertraline, like all antidepressants, carries a boxed warning stating it can increase the risk of suicidal thoughts and behaviors in young people. This is one of several critical safety and efficacy issues under review, prompting many to ask, **why is sertraline under investigation**? Concerns also include its effectiveness compared to placebo and serious side effect litigation.
